News Focus
News Focus
icon url

docsetc

04/21/21 11:07 AM

#101352 RE: BostonTom #101350

I said NASDAQ, because a lot of emerging biotechs starting in the pennies, if they have the goods, have wound up on Nasdaq settling in at about $4.00 - $22.00 pps.

NVAX and DVAX started this way, I was there when they first hit the OTC pages.
icon url

rayf

04/21/21 11:07 AM

#101353 RE: BostonTom #101350

Big deal up list to the QB
From the stinky pink...